NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Special Investigation for Booster Dose of Comirnaty in Children Ages 6 Months Though 4 Years

CompletedN/A

Sponsor: Pfizer

Conditions: SARS-CoV-2, COVID-19

Interventions: COMIRNATY intramuscular injection

Countries: Japan

The purpose of this post-marketing study is to assess the safety of Comirnaty monovalent XBB.1.5. for booster vaccination children ages 6 months though 4 years under actual use medical practice.

Eligibility overview

Sex: ALL

Age: 6 Months to 4 Years

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Children aged 6 months to 4 years at the time of the booster vaccination (4th dose) who (or whose representative) gave written consent to take part in the study.

Exclusion Criteria:

-There are no exclusion criteria for this study.

Locations (1)

Tokyo, Japan